Keybanc maintains FIGS at Overweight, raises price target to $27 from $20
Keybanc maintained its Overweight rating on FIGS and raised its price target to $27 from $20, suggesting a 33.6% upside from the Nov 5 close of $20.21. Recent analyst price targets for FIGS range from $24 to $25.
How this was made

The 30-second read
Why it matters
The higher target may attract new buyers and support price gains.
Market read
Analyst upgrade provides a fresh catalyst for FIGS, modestly relevant to traders.
What to watch
Potential execution risks in FIGS' product rollout and competitive pressure.
Background
Keybanc's analyst note updates FIGS' valuation.
Ticker impact
Keybanc raised its price target for FIGS to $27 from $20, indicating a fresh bullish outlook.
likely upward pressure as investors price in the higher target
Target increase of 35% signals improved expectations, prompting buying interest.
Market effects
May lift sentiment in the health‑tech sector.
U.S. market focus, limited broader impact.
Low
Counterpoint
Target raise could be premature if growth expectations are not met.
Key entities
- analystKeybanc
Equity research firm issuing the target raise.
- companyFIGS
Health‑tech apparel company.



